Health Care
Price
$89.90
+0.13%Market Cap
$51.75B
Day High
$90.21
Day Low
$88.40
Edwards Lifesciences delivered strong revenue growth in Q2 FY2026 driven by TAVR and TMTT, but net income fell 27.4% due to a $188.2 million tax valuation allowance.
Key risk: U.S. Trade Policy and Tariff Impact
Increased tariffs on imports and potential retaliatory tariffs could raise costs and reduce demand for products. The company is pursuing mitigation strategies but cannot predict the outcome, and failure to mitigate could materially harm business and financial results.
Other Health Care Equipment companies